Suchergebnisse - "Mantia, Charlene"

PubPharm (21)

1

Comprehensive multiplexed autoantibody profiling of patients with advanced urothelial cancer

enthalten in: Journal for immunotherapy of cancer | 2024

von Ravi, P. | Freeman, D. | Thomas, J. | +14

2

Enfortumab vedotin-ejfv for the treatment of advanced urothelial carcinoma

enthalten in: Expert review of anticancer therapy | 2022

von Mantia, C. | Sonpavde, G.

3

Longitudinal Evaluation of Circulating Tumor DNA Using Sensitive Amplicon-Based Next-Generation Sequencing to Identify Resistance Mechanisms to Immune Checkpoint Inhibitors for Advanced Urothelial Carcinoma

enthalten in: The oncologist | 2022

von Ravi, P. | Ravi, A. | Riaz, I. | +10

4

FGFR2/3 genomic alterations and response to Enfortumab Vedotin in metastatic urothelial carcinoma

enthalten in: BJUI compass | 2022

von Adib, E. | El Zarif, T. | Jain, R. | +10

5

Sensitivity of treatment-free survival to subgroup analyses in patients with advanced melanoma treated with immune checkpoint inhibitors

enthalten in: Melanoma research | 2022

von Mantia, C. | Werner, L. | Stwalley, B. | +5

6

FGFR2/3 g enomic alterations and response to Enfortumab Vedotin in metastatic urothelial carcinoma

enthalten in: BJUI Compass | 2022

von Adib, E. | El‐Zarif, T. | Jain, R. | +10

7

Treatment-free Survival after Immune Checkpoint Inhibitor Therapy versus Targeted Therapy for Advanced Renal Cell Carcinoma : 42-Month Results of the CheckMate 214 Trial

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2021

von Regan, M. | Jegede, O. | Mantia, C. | +18

CommentIn: Nat Rev Urol. 2022 Jan;19(1):4. - PMID 34845347

8

Treatment-free survival over extended follow-up of patients with advanced melanoma treated with immune checkpoint inhibitors in CheckMate 067

enthalten in: Journal for immunotherapy of cancer | 2021

von Regan, M. | Mantia, C. | Werner, L. | +12

9

Editorial Comment

enthalten in: The Journal of urology | 2021

von Mantia, C. | Sonpavde, G.

CommentOn: J Urol. 2021 Aug;206(2):240-251. - PMID 33835866

10

Transdermal oestrogen for advanced prostate cancer

enthalten in: Lancet (London, England) | 2021

von Mantia, C. | Choudhury, A.

CommentOn: Lancet. 2021 Feb 13;397(10274):581-591. - PMID 33581820